Aardvark Therapeutics AARD
NASDAQ AARD
$1.51 -2.44 (-61.77%)
As of: Oct 23, 2026 · 2:45 PM EDT

Aardvark Therapeutics (AARD) Net Shares Issued and Repurchased (2024 - 2026)

Updated

Analysis

Aardvark Therapeutics (AARD) Net Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn -9.00 Mn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Aardvark Therapeutics 33.21 Mn -40.69 Mn - 262,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 262,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 274,000.00
Sep 30, 2025 171,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 91.19 Mn
Dec 31, 2024 163,000.00
Sep 30, 2024 169,000.00
API Access

Aardvark Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=AARD&period=max&api_key=YOUR_API_KEY